NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Company News » Thermo Fisher gets CE mark for OmniPATH Combi SARS-CoV-2 IgG ELISA test » laboratory-3827738_640(1)

Thermo Fisher gets CE mark for OmniPATH Combi SARS-CoV-2 IgG ELISA test

NS Medical Devices is using cookies

OmniPATH Combi SARS-CoV-2 IgG ELISA test assay is an extension of Thermo Fisher’s COVID-19 antibody test portfolio. (Credit: Belova59 from Pixabay.)

Related Article

The increased importance of supporting decentralised clinical trials during, and after, Covid-19

RECOMMENDED COMPANIES

MOST READ

A new rapid DNA test could predict which Covid-19 patients will need ICU care

The increased importance of supporting decentralised clinical trials during, and after, Covid-19

CES 2021: Five of the best medical technologies from this year’s innovation trade show

How could medical device regulation change under president-elect Biden?

Four breakthrough medical devices that could help to treat Alzheimer’s in the future

Recommended Whitepaper